SCHEMBL6652389

SCHEMBL6652389

CCc1ccncc1-c1nc(-c2ccccc2)cs1

nearest known ligand 0.59

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.59
AR P10275 1/20 0.59
KMT2A Q03164 1/20 0.59
CYP19A1 P11511 10/20 0.58
RAB9A P51151 3/20 0.58
ALDH1A1 P00352 1/20 0.58
NPC1 O15118 1/20 0.58
AXL P30530 1/20 0.54
PBRM1 Q86U86 1/20 0.54
MKNK1 Q9BUB5 1/20 0.54
MKNK2 Q9HBH9 1/20 0.54
PLAU P00749 1/20 0.50
C1S P09871 1/20 0.50
SREBF2 Q12772 2/20 0.49
HPGDS O60760 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6649987 0.97 KDM4E (0.56) KDM4EARKMT2ACYP19A1RAB9A
SCHEMBL6646344 0.90 KDM4E (0.57) KDM4EARKMT2ACYP19A1RAB9A
SCHEMBL6650443 0.88 SREBF2 (0.55) KDM4EARKMT2ACYP19A1RAB9A
SCHEMBL6628863 0.88 CYP19A1 (0.48) KDM4EARKMT2ACYP19A1RAB9A
SCHEMBL6646406 0.86 KDM4E (0.61) KDM4EKMT2ACYP19A1RAB9AALDH1A1
SCHEMBL6628865 0.86 CYP19A1 (0.58) KDM4EKMT2ACYP19A1RAB9AALDH1A1
SCHEMBL6646510 0.86 CDC25A (0.56) KDM4EARKMT2ACYP19A1RAB9A
SCHEMBL6646768 0.85 CYP19A1 (0.56) KMT2ACYP19A1RAB9AALDH1A1NPC1
SCHEMBL6651298 0.84 CYP19A1 (0.47) KDM4EARKMT2ACYP19A1RAB9A
SCHEMBL6626251 0.83 KDM4E (0.52) KDM4EARKMT2ACYP19A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1432706-A2 3-PYRIDYL OR 4-ISOQUINOLINYL THIAZOLES AS C17,20 LYASE INHIBITORS Bayer Pharmaceuticals Corporation (US) 2004-06-30 EP disclosed
WO-2003027085-A2 3-PYRIDYL OR 4-ISOQUINOLINYL THIAZOLES AS C17,20 LYASE INHIBITORS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed